TY - JOUR
T1 - A facile technology for the high-throughput sequencing of the paired VH:VL and TCRβ:TCRα repertoires
AU - Tanno, Hidetaka
AU - McDaniel, Jonathan R.
AU - Stevens, Christopher A.
AU - Voss, William N.
AU - Li, Jie
AU - Durrett, Russell
AU - Lee, Jiwon
AU - Gollihar, Jimmy
AU - Tanno, Yuri
AU - Delidakis, George
AU - Pothukuchy, Arti
AU - Ellefson, Jared W.
AU - Goronzy, Jörg J.
AU - Maynard, Jennifer A.
AU - Ellington, Andrew D.
AU - Ippolito, Gregory C.
AU - Georgiou, George
N1 - Publisher Copyright:
© 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
PY - 2020/4
Y1 - 2020/4
N2 - Natively paired sequencing (NPS) of B cell receptors [variable heavy (VH) and light (VL)] and T cell receptors (TCRβ and TCRα) is essential for the understanding of adaptive immunity in health and disease. Despite many recent technical advances, determining the VH:VL or TCRβ:α repertoire with high accuracy and throughput remains challenging. We discovered that the recently engineered xenopolymerase, RTX, is exceptionally resistant to cell lysate inhibition in single-cell emulsion droplets. We capitalized on the characteristics of this enzyme to develop a simple, rapid, and inexpensive in-droplet overlap extension reverse transcription polymerase chain reaction method for NPS not requiring microfluidics or other specialized equipment. Using this technique, we obtained high yields (5000 to >20,000 per sample) of paired VH:VL or TCRβ:α clonotypes at low cost. As a demonstration, we performed NPS on peripheral blood plasmablasts and T follicular helper cells following seasonal influenza vaccination and discovered high-affinity influenza-specific antibodies and TCRβ:α.
AB - Natively paired sequencing (NPS) of B cell receptors [variable heavy (VH) and light (VL)] and T cell receptors (TCRβ and TCRα) is essential for the understanding of adaptive immunity in health and disease. Despite many recent technical advances, determining the VH:VL or TCRβ:α repertoire with high accuracy and throughput remains challenging. We discovered that the recently engineered xenopolymerase, RTX, is exceptionally resistant to cell lysate inhibition in single-cell emulsion droplets. We capitalized on the characteristics of this enzyme to develop a simple, rapid, and inexpensive in-droplet overlap extension reverse transcription polymerase chain reaction method for NPS not requiring microfluidics or other specialized equipment. Using this technique, we obtained high yields (5000 to >20,000 per sample) of paired VH:VL or TCRβ:α clonotypes at low cost. As a demonstration, we performed NPS on peripheral blood plasmablasts and T follicular helper cells following seasonal influenza vaccination and discovered high-affinity influenza-specific antibodies and TCRβ:α.
UR - http://www.scopus.com/inward/record.url?scp=85084663519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084663519&partnerID=8YFLogxK
U2 - 10.1126/sciadv.aay9093
DO - 10.1126/sciadv.aay9093
M3 - Article
C2 - 32426460
AN - SCOPUS:85084663519
SN - 2375-2548
VL - 6
JO - Science Advances
JF - Science Advances
IS - 17
M1 - aay9093
ER -